USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment
HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.
HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key.
HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.
HQ Team December 11, 2023: Australian researchers reveal that having a cat can potentially double a person’s risk of schizophrenia-related disorders transmitted through.
HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following.
By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US, the Netherlands, and Denmark are higher than.
HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.
HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.
HQ Team November 10, 2023: A drug taken intravenously or inhaled proved to be more addictive as it enters the human brain more.
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.